Aclarion to enroll around 25% of patients in CLARITY trial by Q2
Source: SeekingAlpha
2026-01-08 06:18:36 ET
More on Aclarion, Inc.
- Seeking Alpha’s Quant Rating on Aclarion, Inc.
- Historical earnings data for Aclarion, Inc.
- Financial information for Aclarion, Inc.
Read the full article on Seeking Alpha
For further details see:
Aclarion to enroll around 25% of patients in CLARITY trial by Q2
Aclarion Inc.
NASDAQ: ACON
ACON Trading
0.0% G/L:
$3.47 Last:
48,424 Volume:
$3.37 Open:
ACON Latest News
February 03, 2026 06:00:00 am
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
ACON Stock Data
$2,332,433
671,344
N/A
4
N/A
Healthcare Providers & Services
Healthcare
US
Broomfield
